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Cylindrospermopsin is a cyanobacterial toxin of increasing environmental importance, as it
can lead to disease if orally or intravenously absorbed. However, its in vivo lung impair-
ment has not been documented. Thus, we aimed at verifying whether cylindrospermopsin
can induce lung injury and establish its putative dependence on the time elapsed since
exposure.
BALB/c mice were intratracheally injected with either saline (NaCl 0.9%, 50 mL, SAL group,
n ¼ 12) or a sublethal dose (70 mg/kg) of semi-puriﬁed extract of cylindrospermopsin (CYN
groups, n ¼ 52). Lung mechanics, histological and biochemical analyses, and cylin-
drospermopsin presence in lungs and liver were determined in independent groups at 2, 8,
24, 48, and 96 h after cylindrospermopsin instillation.
There was a signiﬁcant increase in static elastance at 24 and 48 h after exposure to
cylindrospermopsin, while viscoelastic component of elastance and viscoelastic pressure
rose at 48 h. Alveolar collapse augmented in CYN groups at 8 h. A signiﬁcant increase in
polymorphonuclear inﬂux into lung parenchyma, as well as a higher myeloperoxidase
activity started off at 24 h. Exposure to cylindrospermopsin increased lipid peroxidation
and superoxide dismutase activity and reduced catalase activity in CYN groups. The toxin
was detected in lungs and liver of all CYN mice.
In conclusion, cylindrospermopsin exposure impaired lung mechanics, which was
preceded by lung parenchyma inﬂammation and oxidative stress.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Cyanobacteria are a group of prokaryotic organisms
primarily found in freshwater environments, especially in
tropical regions, where warmwater temperatures and high
nutrient concentrations often allow their growth (SakerRio de Janeiro, Insti-
gas Filho 373, Room
RJ, Brazil. Tel.: þ5521
otmail.com(W.A.Zin).
lsevier OA license.and Eaglesham, 1999). Of major concern is the production
of toxins that have become recognized as potent hazards in
drinking water throughout the world (Falconer and
Humpage, 2006). Our previous studies with a cyanotoxin
(Picanço et al., 2004; Soares et al., 2007; Carvalho et al.,
2010; Casquilho et al., 2011) showed that a single intra-
peritoneal sub-lethal dose (40 mg/kg BW) of microcystin-LR
(MCYST-LR) impairs lung mechanics and increases poly-
morphonuclear inﬂux in lung parenchyma.
The toxic alkaloid cylindrospermopsin can be
produced by a range of cyanobacterial species, like
Cylindrospermopsis raciborskii (Ohtani et al., 1992),
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diopsis curvata (Li et al., 2001), and Umezakia natans
(Harada et al., 1994). In 1978, a serious poisoning of
humans resulting from consumption of water contami-
nated with the toxic cyanobacterium C. raciborskii took
place in Palm Island, Australia. It was known as the “Palm
Island mystery disease”, and well over 100 children had
to be admitted to the hospital showing various symp-
toms of gastroenteritis (Byth, 1980; Bourke et al., 1983;
Grifﬁths and Saker, 2003; Berry et al., 2009). Since that
time a great deal of attention has been dedicated to
cylindrospermopsin, although there is no data in the
literature reporting the dose-dependence of human
beings to that toxin. Poisoning resulted from recreation
(Chorus et al., 2000; Rao et al., 2002) and possible
accumulation in the food-web (Saker and Eaglesham,
1999); transmission from mice females to their fetuses
(Paerl et al., 2001; Codd et al., 2005; Falconer and
Humpage, 2006; Rogers et al., 2007) has also been
reported.
Owing to its high solubility in water and low rate of bio-
and photodegradation, signiﬁcant amounts of cylin-
drospermopsin can be expected to occur in the water
column (Wormer et al., 2008, 2010). The toxin concentra-
tions in the European environment were found to amount
up to 12.1 mg/L in Germany (Rücker et al., 2007), up to
9.4 mg/L in Spain (Quesada et al., 2006), and up to 18.4 mg/L
in Italy (Bogialli et al., 2006). US EPA classiﬁed cylin-
drospermopsin as a compound with high priority for
hazard characterization (U.S. Environmental Protection
Agency, 2001).
Despite considerable research, much remains to be
disclosed with respect to the toxicity of cylindrospermop-
sin. It is known that the toxin irreversibly inhibits protein
synthesis. However, themechanisms involved in its toxicity
andmetabolism are not well understood. Terao et al. (1994)
reported ribosome detachment from the rough endo-
plasmic reticulum, and the linkage of an active metabolite
of cylindrospermopsin to DNA or RNA, with consequent
blockage of translation, was also suggested (Shaw et al.,
2000). Cylindrospermopsin can also induce DNA fragmen-
tation, chromosome losses, and possibly carcinogenicity
(Humpage et al., 2000, 2005; Falconer and Humpage, 2001;
Shen et al., 2002). Cylindrospermopsin toxicity seems to
present two toxic responses (Falconer, 2008): The rapid
toxicity appears to be mediated by CYP450 activation,
which generates more toxic metabolites, while the longer-
term toxicity is due to protein synthesis inhibition
(Humpage et al., 2005).
Although lethal doses of cylindrospermopsin can
damage the liver, kidney, lung, heart, stomach and the
vascular system (Hawkins et al., 1985), there are no reports
in the literature investigating in vivo pulmonary damage
produced by sub-lethal doses of cylindrospermopsin.
Moreover, the understanding of the effects of these doses of
the toxin is relevant because human beings are often
exposed to low doses of cyanotoxins. Hence, in the present
study we aimed at verifying whether a single sub-lethal
dose of cylindrospermopsin can induce lung injury, and
establish its putative dependence on the time elapsed since
exposure.2. Materials and methods
2.1. Animals
BALB/c male mice (6–7 week of age) were purchased
from CEMIB (Multidisciplinary Center for Biological Inves-
tigation, University of Campinas, Campinas, Brazil). The
animals were housed in plastic cages with absorbent
bedding material and maintained on a 12-h daylight cycle.
Food andwater were provided ad libitum. The experimental
protocol was approved by the Ethics Committee on the Use
of Animals, Health Sciences Center, Federal University of
Rio de Janeiro (Protocol IBCCF 012).2.2. Experimental procedures
Two separate experiments, with equal procedures, were
necessary for this study. The ﬁrst one used thirty-four mice,
randomly divided into 6 groups (5–6 animals per group) for
pulmonary mechanics and histological analyses. The
second experiment had 30 animals sacriﬁced for all
biochemical analyses.
We had 4 control animals at all time points in the ﬁrst
set of experiments. After running a one-way ANOVA fol-
lowed by Bonferroni’s multiple comparisons test using the
mechanics data, all control groupswere statistically similar.
Thus, one animal was randomly picked up from each group
and, thus, SAL group was formed (n ¼ 5). In the second
batch of animals 5 mice were used as controls. SAL animals
received a single intratracheal instillation (i.t.) of 50 mL of
saline solution (NaCl 0.9%). Cylindrospermopsin groups
(CYN) received a single sublethal dose of semi-puriﬁed
extract of cylindrospermopsin (70 mg/kg body weight, i.e.,
45–55 mL, i.t.). This dose was chosen based on the cylin-
drospermopsin LD50 in mice (i.p.), namely, 200 mg/kg BW
(Terao et al., 1994). All animals (25–30 g) were analyzed 2,
8, 24, 48 and 96 h after instillation. For intratracheal
instillation mice were anesthetized with sevoﬂurane, and
saline or cylindrospermopsin was gently instilled into their
tracheas with the aid of an ultra-ﬁne U-100 insulin syringe.
The animals rapidly recovered after instillation.
All animals received humane care in compliance with
the “Principles of Laboratory Animal Care” formulated by
the National Society for Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared by
the Academy of Sciences, USA.2.3. Cylindrospermopsin semi-puriﬁed extract production
The animals were exposed to a semi-puriﬁed extract of
C. raciborskii. The cylindrospermopsin producer strain CYP
011K, kindly provided by Dr. Andrew Humpage and Dr.
Peter Baker (Australian Water Quality Centre, Adelaide,
Australia) was cultured in ASM-1 medium, the lyophilized
biomass was extracted in ultrapure water, centrifuged and
passed through a C18 cartridge to remove part of thematrix
interference. The process ensured the removal of any cya-
nobacterial LPS in the extract. The extraction step and HPLC
analysis of toxin content were done according to Welker
et al. (2002).
V.R. Oliveira et al. / Toxicon 60 (2012) 764–7727662.4. Pulmonary mechanics
At 2, 8, 24, 48 and 96 h after instillation of saline or
cylindrospermopsin the animals were sedated with diaz-
epam (1 mg, i.p.), anesthetized with pentobarbital sodium
(20 mg/kg BW, i.p.), tracheotomized, and a snugly ﬁtting
cannula (0.8 mm i.d.) was introduced into the trachea. The
animals were then paralyzed with pancuronium bromide
(0.1 mg/kg, i.v.) and mechanically ventilated with
a constant-ﬂow ventilator (Samay VR15, Universidad de la
Republica, Montevideo, Uruguay) with respiratory
frequency of 100 breaths/min, tidal volume of 0.2mL, ﬂowof
1 mL/s, and positive end-expiratory pressure of 2 cmH2O.
The anterior chest wall was then surgically removed.
A pneumotachograph (15mm i.d., length 4.2 cm, distance
between side ports ¼ 2.1 cm) (Mortola and Novoraj, 1983)
was connected to the tracheal cannula for themeasurements
of airﬂow (V0). Lung volume (VT)wasmeasured byﬂowsignal
integration. The pressure gradient across the pneumotacho-
graph was determined by means of a Valydine MP45-2
differential pressure transducer (Engineering Corp., North-
ridge, CA, USA). The ﬂow resistance of the equipment (Req),
tracheal cannula included, was constant up to ﬂow rates of
26 mL/s and amounted to 0.12 cmH2OmL1 s. Equipment
resistive pressure (¼Req$V0) was subtracted from pulmonary
resistive pressure so that the present results represent
intrinsic values. Tracheal pressure was measured with a Val-
idyne MP-45 differential pressure transducer (Engineering
Corp. Northridge, CA, USA). All signals were conditioned and
ampliﬁed in a Beckman type R Dynograph (Schiller Park, IL,
USA). Flow and pressure signals were passed through 8-pole
Bessel low-passﬁlters (902LPF, FrequencyDevices, Haverhill,
MA,USA)with the corner frequency set at 100Hz, sampled at
200 Hz with a 12-bit analog-to-digital converter (DT2801A,
Data Translation, Marlboro, MA, USA), and stored on
a microcomputer. All data were collected using LABDAT
software (RHT-InfoData Inc., Montreal, QC, Canada).
Lung resistive (DP1) and viscoelastic/inhomogeneous
(DP2) pressures, total resistive pressure drop
(DPtot ¼ DP1 þ DP2), static elastance (Est), and viscoelastic
component of elastance (DE) were measured by the end-
inﬂation occlusion method (Bates et al., 1985, 1988).
Brieﬂy, after end-inspiratory occlusion, there is an initial fast
drop in transpulmonary pressure (DP1) from the pre-
occlusion value down to an inﬂection point (Pi) followed
by a slow pressure decay (DP2), until a plateau is reached.
This plateau corresponds to the elastic recoil pressure of the
lung (Pel). DP1 selectively reﬂects airway resistance in
normal animals and humans and DP2 reﬂects stress relax-
ation, or viscoelastic properties of the lung, together with
a small contribution of time constant inequalities at the
peripheral airspaces (Bates et al., 1988; Saldiva et al., 1992).
Lung static elastance (Est) was calculated by dividing Pel by
tidal volume. DE was calculated as the difference between
static and dynamic elastances and reﬂects the viscoelastic
component of elastance (Bates et al., 1985, 1988).
2.5. Histological study
Heparin (1000 IU) was intravenously injected immedi-
ately after the determination of pulmonary mechanics. Thetrachea was clamped at end-expiration and the abdominal
aorta and vena cava were sectioned, yielding a massive
hemorrhage that quickly euthanized the animals. To
perform the morphometric study, the lungs were isolated
at end-expiratory lung volume, quick-frozen by immersion
in liquid nitrogen, and ﬁxed with Carnoy’s solution (etha-
nol:cloroform:acetic acid, 70:20:10) at 70 C. After 24 h,
ethanol concentrations were progressively increased (70,
80, 90 and 100%, respectively, 1 h in each solution, at
20 C). The lungs were then kept in 100% ethanol for 24 h
at 4 C (Nagase et al., 1992). After ﬁxation, tissue blocks
were embedded in parafﬁn and 3-mm thick slices were cut,
mounted, and stained with hematoxylin–eosin. Two
investigators, who were unaware of the origin of the
encoded material, examined the samples microscopically.
Morphometric analysis was performed with an inte-
grating eyepiecewith a coherent systemmadeof a 100-point
and 50-lines (known length) grid coupled to a conventional
light microscope (Axioplan, Zeiss, Oberkochen, Germany).
The fraction areas of collapsed and normal alveoli were
determined by the point-counting technique at a magniﬁca-
tion of 200 across 10 random non-coincident microscopic
ﬁelds per animal. Points fallingonnormal or collapsed alveoli
were expressed as percentage of total points of the grid
(Weibel et al., 1966; Gundersen et al., 1988). Polymorpho-
(PMN) and mononuclear (MN) cells, and pulmonary tissue
were evaluated at 1000 magniﬁcation across 10 random
non-coincident microscopic ﬁelds in each animal (total area
of 10,000 mm2/ﬁeld). Points falling onpulmonary tissuewere
counted to determine lung tissue area in each ﬁeld. PMNand
MN cells were counted, and represented by total number of
cells per area of lung tissue (Gundersen et al., 1988).
2.6. Biochemical analyses
The left lung of animals was used for the determination
of total protein content by the Bradford’s method (1976) and
inﬂammation and oxidative stress analyses. The right lung
and the liver of each animal were isolated for cylin-
drospermopsin content analysis by enzyme-linked immu-
nosorbent assay (ELISA). Brieﬂy, the tissues were
homogenized in buffer solution (0.1 g of tissue/mL) con-
taining EDTA (0.1 mM), DTT (1 mM), Tris–HCl, pH 7.0
(50 mM) and the protease inhibitor phenylmethylsulphonyl
ﬂuoride (0.1 mM), at 4 C, using a Tissuemiser homogenizer
(Fisher Scientiﬁc, Hampton, NH, USA). The resultant
homogenates were centrifuged (10,000  g) and the
supernatants were stored in glass vials at 20 C until the
analyses were done.
2.6.1. Myeloperoxidase (MPO)
Inﬂammatory changes were examined by MPO activity
in the supernatant of lung homogenates. Absorbances were
determined at 655 nmusing a plate reader (Model 550, Bio-
Rad, Hercules, CA, USA) (Suzuki et al., 1983). Myeloperox-
idase activity was expressed in mU/mg protein.
2.6.2. Lipid peroxidation, superoxide dismutase (SOD) and
catalase (CAT) activities
The thiobarbituric acid-reactive substances (TBARS)
method analyzed malondialdehyde (MDA) products
Fig. 1. Lung static elastance (Est), viscoelastic component of elastance (DE),
and pressures spent against resistive (DP1), viscoelastic/inhomogeneous
(DP2), and total resistive mechanical components (DPtot ¼ DP1 þ DP2) of 5–
6 mice per group measured 2, 8, 24, 48 and 96 h after instillation of 50 mL of
saline solution (SAL) or 70 mg/kg of cylindrospermopsin (CYN groups).
Values are mean þ SEM. Different letters mean signiﬁcantly different values
(p < 0.05).
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1990). MDA levels were determined at 532 nm and
expressed as nmol/mg protein. SOD activity was assayed
by measuring inhibition of adrenaline auto-oxidation as
absorbance at 480 nm and was expressed as SOD equiv-
alents (U/mg protein) (Bannister and Calabrese, 1987).
CAT activity was measured by the rate of decrease in
hydrogen peroxide concentration at 240 nm and
was expressed as CAT equivalents (U/mg protein) (Aebi,
1984). A spectrophotometer was used in all determina-
tions (Ultrospec 2100 pro, Amersham-Biosciences, Buck-
inghamshire, UK).
2.7. Cylindrospermopsin determination in tissues
Cylindrospermopsin was detected in lung and liver
homogenate supernatants by ELISA commercial kits
(Beacon Analytical Systems, Portland, ME, USA) according
to the manufacturer’s instructions. The limit of quantiﬁca-
tion of this method corresponds to 0.1 ng/m. Final values
were expressed as ng of cylindrospermopsin/g of pulmo-
nary or hepatic tissue.
2.8. Statistical analysis
SigmaStat 3.11 statistical software package (SYSTAT,
Chicago, IL, USA) was used. The normality of the data
(Kolmogorov–Smirnov test with Lilliefors’ correction) and
the homogeneity of variances (Levene median test) were
tested. If both conditions were satisﬁed, one-way ANOVA
was used, followed by Bonferroni’s test for multiple
comparisons when needed. If one or both conditions was
not satisﬁed Kruskal–Wallis ANOVA was used followed by
a Dunn’s test. In all instances the signiﬁcance level was set
at 5% (p < 0.05).
3. Results
3.1. Pulmonary mechanics
A single sublethal dose of cylindrospermopsin signiﬁ-
cantly increased Est at 24 and 48 h after intratracheal
instillation; DE and DP2 were higher than SAL at 24 h after
exposure to cylindrospermopsin. DP1 and DPtot did not
differ among groups (Fig. 1).
3.2. Histological study
Fig. 2 shows photomicrographs of lung parenchyma in
SAL and CYN groups. Table 1 depicts the fraction area of
alveolar collapse and the content of polymorpho- (PMN)
and mononuclear (MN) cells in pulmonary parenchyma.
Exposure to cylindrospermopsin increased the fraction
area of collapse and PMN inﬂux into the lung parenchyma
compared with SAL. The increase in alveolar collapse star-
ted at 8 h, reaching a maximum at 48 h, diminished at 96 h,
but did not return to SAL values. A higher amount of PMN/
mm2 was observed from 24 until 96 h. On the other hand,
a decrease in the MN cell content was found in all CYN
groups in relation to SAL (Table 1 and Fig. 2).3.3. Biochemical analyses
Fig. 3 depicts MPO, SOD and CAT activities and MDA
levels in lung homogenates of SAL and CYN groups. There
was a signiﬁcant increase in MPO activity from 24 to 96 h,
reaching a peak at 48 h after CYN exposure. SOD activity
was signiﬁcantly higher at 2 and 8 h, progressively
returning to SAL values at 96 h. There was a signiﬁcant
decrease in CAT activity at 48 and 96 h, as compared with
SAL. MDA levels increased signiﬁcantly from 8 until 48 h
after exposure to cylindrospermopsin.3.4. Cylindrospermopsin determination
Fig. 4 presents cylindrospermopsin concentrations in the
liver and lung cytosols. There was a higher amount of
cylindrospermopsin in the lung at the ﬁrst 24 h after intra-
tracheal instillation and in the liver the concentration
increased signiﬁcantly at 96 h after intratracheal instillation.
4. Discussion
Our results demonstrated that a single sub-lethal dose
of cylindrospermopsin intratracheally administered
Fig. 2. Photomicrographs of lung parenchyma in representative animals in each group. SAL, CYN2, CYN8, CYN24, CYN48 and CYN96 correspond to mice studied at
2, 8, 24, 48 and 96 h after instillation of 50 mL of saline solution (SAL) or 70 mg/kg of cylindrospermopsin (CYN groups). Note that at 48 h the lung depicts the
highest amount of airspace collapse.
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increased elastic and viscoelastic components of lung
mechanics. Exposure to cylindrospermopsin also induced
damage to pulmonary parenchyma as indicated by the
increased amount of alveolar collapse, PMN inﬂux, and
oxidative stress. In the lungs the toxin concentration
decreased and in the liver it increased as a function of time.
In the present studywe used a sub-lethal dose (0.07mg/
kg) of cylindrospermopsin once human and animal expo-
sures to non-lethal concentrations are more common than
acute intoxications. Indeed, no death occurred during the
experiments. The literature shows that LD50 of this toxin
presents a toxicity that varies in the time of death accord-
ing to the intraperitoneal dose in mice: 2.0 mg/kg BW
causes death in 24 h and 0.2 mg/kg BW along 5–6 days
(Norris et al., 2002). Hence, this may suggest its slow and
progressive process of poisoning in the face of sub-lethal
doses. In fact, animal and human exposures to these
doses occur more frequently than lethal events, damaging
many organs, such as liver, kidneys, thymus, heart and lungTable 1
Morphometry and cellularity in lung parenchyma.
Groups Alveolar
collapse (%)
PMN (cells
 103/mm2)
MN (cells
 103/mm2)
SAL 25.2  2.3a 5.4  1.1a 11.6  1.4a
CYN2 33.5  2.4a,b 5.6  1.2a 9.0  1.1a,b
CYN8 43.1  4.8b 7.6  0.2a 7.7  1.1a,b
CYN24 44.4  3.0b 12.1  1.2b 4.5  0.4b
CYN48 68.9  1.4c 15.2  1.1b 4.3  0.4b
CYN96 55.3  4.2b,c 13.8  0.8b 3.9  0.5b
Values are mean  SEM of 5–6 animals in each group. Data were gathered
from ten random, non-coincident ﬁelds per mouse 2, 8, 24, 48 and 96 h
after intratracheal instillation of 50 mL of saline solution (SAL) or 70 mg/kg
of cylindrospermopsin (CYN groups). Different letters mean signiﬁcantly
different values (p < 0.05).(Falconer et al., 1999; Humpage and Falconer, 2003; Pegram
et al., 2007).
We could detect a higher concentration of cylin-
drospermopsin in the lung along the ﬁrst 24 h after intra-
tracheal instillation (Fig. 4), possibly due to the direct
pathway of the toxin. Furthermore, we observed that the
concentration in the liver increased signiﬁcantly at 96 h
after instillation. Since cylindrospermopsin was adminis-
tered by the intratracheal route, it rapidly reached the lung,
then going to the target organs, such as liver and kidneys.
Considering that the kinetics of cylindrospermopsin and its
metabolites in the liver, and mainly in other organs and
bloodstream, is poorly understood, the present work does
not provide a proven explanation for the increase in the
toxin concentration in the liver at 96 h after intoxication.
The kidneys seem to be the most sensitive organs in
mice exposed sub-chronically to cylindrospermopsin
(Humpage and Falconer, 2003), while the liver plays a key
role in the metabolism of that toxin, with the involvement
of cytochrome P450 (CYP450) enzymatic system. Froscio
et al. (2003) observed protection from cylindrospermop-
sin toxicity by CYP450 inhibitors; thus it is possible that the
early and higher toxicity is related to CYP450-dependent
activation, once more toxic cylindrospermopsin metabo-
lites can spread by the bloodstream (Norris et al., 2001).
Indeed, these authors reported the presence of the toxin’s
metabolites in the liver and kidney tissues of mice exposed
intraperitoneally to radiolabelled cylindrospermopsin.
According to Bryant and Knights (2010), the parent cylin-
drospermopsin can also enter the bloodstream and reach
other organs. Unfortunately, there is no information in the
literature concerning the bloodstream transport of cylin-
drospermopsin metabolites. The later toxicity would be
a consequence of protein synthesis inhibition (Runnegar
et al., 2002).
Fig. 3. Determination of myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT) activities and malondialdehyde (MDA) levels lung homogenates.
SAL, CYN2, CYN8, CYN24, CYN48 and CYN96 correspond to mice studied at 2, 8, 24, 48 and 96 h after instillation of 50 mL of saline solution (SAL) or 70 mg/kg of
cylindrospermopsin (CYN groups). Bars are mean þ SEM and boxes show interquartile (25–75%) range and horizontal lines represent median values. Different
letters mean signiﬁcantly different values (p < 0.05).
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means of several mechanisms, including lipid peroxidation
with formation of pro-inﬂammatory molecules such as
thromboxane, oxidation of proteins that leads to the release
of proteases and inactivation of antioxidant and protease-
inhibiting enzymes, and also alteration of the expression of
transcription factors such as nuclear factor (NF)-kB, which
generates an enhanced expression of pro-inﬂammatory
genes (Fialkow et al., 1994; Chow et al., 2003). There is
evidence that intoxication with cyanotoxins may lead toFig. 4. Concentration of cylindrospermopsin in the cytosol of cells from liver
and lung analyzed by ELISA of 5 mice per group measured 2, 8, 24, 48 and
96 h after instillation of 70 mg/kg of cylindrospermopsin (CYN groups).
Values are mean þ SEM. Different letters mean signiﬁcantly different values
(p < 0.05).oxidative stress and lesion in some organs, such as liver,
kidney and lungs (Moreno et al., 2005; Carvalho et al., 2010).
In mice liver there are also reports of cylindrospermopsin-
induced depletion of glutathione, a tripeptide that plays an
important role in the detoxiﬁcation of many xenobiotics and
participates in cellular defense against oxidative damage
(Runnegar et al., 1994; Humpage et al., 2005). In the present
study, the latter could also contribute to the toxicity induced
by cylindrospermopsin, once depleted glutathione content
would result in a less important removal of reactive oxygen
species. Generally, as a result of initial oxidative stress, there
is an activation of the antioxidant defense system in order to
minimize the tissue damage. In this line, we analyzed anti-
oxidant enzymes involved in the balance of redox status
(SOD and CAT) aswell as amarker of oxidative damage (lipid
peroxidation) in samples of lung tissue of mice (Fig. 3). SOD
catalyzes superoxide anion dismutation to molecular
oxygen and hydrogen peroxide. The latter is detoxiﬁed by
CAT activity and both enzymes can be triggered after
a poisoning event with microcystins (Pandey et al., 2003).
The present study identiﬁed a crescent increase in SOD
activity until 8 h after exposure to cylindrospermopsin, thus
conﬁrming that the native toxin could increase superoxide
anion production. SOD activity was reduced after the initial
effect until returning to control levels in 96 h, in linewith the
notion that SOD is the ﬁrst defense line against ROS (Foronjy
et al., 2006). Additionally, SOD activity could have dimin-
ished as a consequence of the decreasing amount of toxin in
the lung as time progressed (Fig. 4).
On theotherhand, CATactivitywassimilar to control until
24 h after cylindrospermopsin exposure and signiﬁcantly
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mentioned. Since CAT takes part in catalyzing hydrogen
peroxide, its performance depends on SOD substrate, i.e.,
hydrogenperoxide.Moreover, the reduction inCATactivity in
CYN48 and CYN96 is in agreement with the increase inMPO
in these groups (Fig. 3). MPO also uses hydrogen peroxide as
a substrate, whose afﬁnity is higher for MPO than for CAT.
Hydrogen peroxide is a stable ROS, so in inﬂammatory
conditions such as increased PMN inﬂux it could react more
with MPO after 24 h, leading to the production of another
ROS, the hypochlorous acid, which also contributes to
oxidative stress.
Lipid peroxidation is a cascade of events which can
generate lipid subproducts that can be measured to quan-
tify oxidative damage (Jayaraj et al., 2006; Weng et al.,
2007). There are no studies relating cylindrospermopsin
exposure to oxidative stress in the lung. Our study
describes a statistically signiﬁcant increase in lipid perox-
idation from 8 to 48 h after exposure to the toxin, with
return to control parameters in 96 h (Fig. 3). Therefore, we
can state that oxidative damage took place in mice lungs as
a consequence of antioxidant imbalance generated by
cylindrospermopsin. Thus, we believe that this effect could
increase the fraction areas of alveolar collapse from 8 h on
and also possibly yielded the recruitment of inﬂammatory
cells into the lung parenchyma, indicated by the increase in
myeloperoxidase activity and polymorphonuclear cells
from 24 h on after exposure to the toxin (Fig. 2, Table 1).
Despite the main hepatic and renal effects, two studies
showed that the lungs can also be affected by exposure to
cylindrospermopsin (Hawkins et al., 1985; Bernard et al.,
2003). These authors reported that mice intraperitoneally
injected with lethal doses of this toxin showed signals of
congestion and hemorrhage in the lungs. Indeed, our
histopathological study revealed changes in pulmonary
parenchyma, evidenced by discrete edema, thickening of
alveolar septa and collapsed areas in CYN groups (Fig. 2,
Table 1). However, we did not observe intra-alveolar
hemorrhage certainly due to the sub-lethal dose adminis-
tered. Lungs may have been damaged by ROS production
derived from native cylindrospermopsin and its metabo-
lites or by activated defense cells along the inﬂammatory
process, which could explain the increase in alveolar
collapsed areas after 24 h in our mice injected with the
toxin (Fig. 2, Table 1).
As a result of lung inﬂammation, oxidative stress and
lesion, pulmonary mechanics became impaired as a conse-
quence of stiffer lungs, indicated by lung static elastance
(Est) and viscoelastic components (DE and DP2, Fig. 1) at
48 h after exposure. Even though cylindrospermopsin was
intratracheally administered, it triggered lung mechanical
alterations later than microcystin-LR by intra-peritoneal
injection (Soares et al., 2007; Carvalho et al., 2010;
Casquilho et al., 2011). Another difference was that these
authors also found an increase in the pressure spent to
overcome central airway resistance which was not
produced by cylindrospermopsin.
Finally, based on our results and on the literature, we
might hypothesize two patterns of effects in the lungs after
cylindrospermopsin exposure. The former would be related
to the direct route by which the toxin reaches the lung andpossibly ellicits its early effects, such as oxidative stress
through ROS production. The second one is characterized
by pulmonary inﬂammatory response and functional
changes, possibly induced by the action of early produced
ROS and protein synthesis inhibition.
Our study presents limitations: (1) its design does not
allow gathering information on the dose–response proﬁle
of the lesions; (2) we chose the intratracheal instillation to
guarantee that the administered toxin would reach the
lung, thus avoiding its eventual swallowing. The latter
could occur if the intranasal (i.n.) route were used. Human
beings are not expected to be contaminated by the intra-
tracheal route; and, (3) It was not possible to calculate the
mass balance of cylindrospermopsin in the tissues, and
thus we cannot warrant that the detected values represent
the total concentrations of the toxin in the tissues, i.e.,
maybe ELISA could not detect cylindrospermopsin attached
to other cellular organelles, such as ribosomes and/or other
translational components (Froscio et al., 2008).
5. Conclusion
We conclude that the aggression of sub-lethal concen-
tration of cylindrospermopsin to otherwise healthy mice
impaired lung mechanics, which was preceded by lung
parenchyma inﬂammation and oxidative stress.
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